Lakewood Ranch fertility company posts 2023 results, stock trading soars

Fertility company INVO Bioscience posted its 2023 financial results Tuesday, showing a loss of $8 million, according to a news release. Despite its overall loss, the company showed tremendous growth, particularly on the heels of an acquisition in the fourth quarter, and its trading activity spiked.

Revenue for the company, which aims to make assisted reproductive technology more accessible worldwide, was $3.02 million in 2023, compared with $822,196 the previous year, the release says, representing a 267% increase.

Its fourth quarter revenue showed even more pronounced growth. INVO reported revenue of $1.38 million in the fourth quarter, a 397% increase from the same time in 2022, when revenue was $278,142, according to the release.